BRPI0407381A - 4-aminopirimidino-5-ona - Google Patents
4-aminopirimidino-5-onaInfo
- Publication number
- BRPI0407381A BRPI0407381A BR0407381-9A BRPI0407381A BRPI0407381A BR PI0407381 A BRPI0407381 A BR PI0407381A BR PI0407381 A BRPI0407381 A BR PI0407381A BR PI0407381 A BRPI0407381 A BR PI0407381A
- Authority
- BR
- Brazil
- Prior art keywords
- aminopyrimidine
- compounds
- preparation
- cancer
- cyclin
- Prior art date
Links
- WYPGFVLAEWKLCO-UHFFFAOYSA-N 4-amino-4h-pyrimidin-5-one Chemical compound NC1N=CN=CC1=O WYPGFVLAEWKLCO-UHFFFAOYSA-N 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 abstract 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 108091007914 CDKs Proteins 0.000 abstract 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
4-AMINOPIRIMIDINO-5-ONA. Novos derivados 4-aminopirimidino-5-onas da formula I, em que R¬ 1¬ e R¬ 2¬ são como definidos no relatório descritivo, são como definidos no relatório descritivo, são revelados. Estes compostos inibem cinases ciclina-dependentes. em particular cinase ciclina-dependente 4 (Cdk4). Estes compostos e seus sais e ésteres farmaceuticamente aceitáveis têm atividade antiproliferativas e são úteis no tratamento ou controle de câncer, em particular tumores sólidos. Esta invenção é também direcionada às composições farmacêuticas contendo tais compostos, seus usos para tratar ou controlar câncer, a um processo de sua preparação e aos intermediários úteis em sua preparação.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44627303P | 2003-02-10 | 2003-02-10 | |
| US51492603P | 2003-10-28 | 2003-10-28 | |
| PCT/EP2004/000971 WO2004069139A2 (en) | 2003-02-10 | 2004-02-03 | 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0407381A true BRPI0407381A (pt) | 2006-02-07 |
Family
ID=32853425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0407381-9A BRPI0407381A (pt) | 2003-02-10 | 2004-02-03 | 4-aminopirimidino-5-ona |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7157455B2 (pt) |
| EP (1) | EP1628619A2 (pt) |
| JP (1) | JP2006523183A (pt) |
| KR (1) | KR100717099B1 (pt) |
| AR (1) | AR043693A1 (pt) |
| AU (1) | AU2004210408A1 (pt) |
| BR (1) | BRPI0407381A (pt) |
| CA (1) | CA2512915A1 (pt) |
| CL (1) | CL2004000226A1 (pt) |
| EA (1) | EA009412B1 (pt) |
| EC (1) | ECSP055958A (pt) |
| HR (1) | HRP20050689A2 (pt) |
| IL (1) | IL169626A0 (pt) |
| MA (1) | MA27716A1 (pt) |
| MX (1) | MXPA05008333A (pt) |
| MY (1) | MY137555A (pt) |
| NO (1) | NO20053410L (pt) |
| PL (1) | PL382309A1 (pt) |
| RS (1) | RS20050610A (pt) |
| TN (1) | TNSN05188A1 (pt) |
| TW (1) | TWI293881B (pt) |
| WO (1) | WO2004069139A2 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211576B2 (en) * | 2004-04-20 | 2007-05-01 | Hoffmann-La Roche Inc. | Diaminothiazoles |
| US7405220B2 (en) | 2004-06-09 | 2008-07-29 | Hoffmann-La Roche Inc. | Pyrazolopyrimidines |
| ES2313556T3 (es) * | 2005-05-25 | 2009-03-01 | F. Hoffmann-La Roche Ag | Biomarcador para el control de la respuesta de los inhibidores de la cdk en la clinica. |
| US7705009B2 (en) * | 2005-11-22 | 2010-04-27 | Hoffman-La Roche Inc. | 4-aminopyrimidine-5-thione derivatives |
| CN101316823B (zh) | 2005-12-01 | 2013-05-22 | 霍夫曼-拉罗奇有限公司 | 用作抗癌剂的作为p53和MDM2蛋白之间相互作用的抑制剂的2,4,5-三苯基咪唑啉衍生物 |
| WO2007113005A2 (en) * | 2006-04-03 | 2007-10-11 | European Molecular Biology Laboratory (Embl) | 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors |
| US9408848B2 (en) | 2008-08-15 | 2016-08-09 | Georgetown University | Fluorescent CDK inhibitors for treatment of cancer |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| BR112016030787B1 (pt) * | 2014-07-01 | 2022-12-20 | Takeda Pharmaceutical Company Limited | Entidade química, composição farmacêutica e seu uso |
| US12595261B2 (en) | 2019-06-06 | 2026-04-07 | Beijing Tide Pharmaceutical Co., Ltd. | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof |
| US20250009745A1 (en) * | 2021-02-05 | 2025-01-09 | Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. | Cdk inhibitor |
| IL319771A (en) * | 2022-09-22 | 2025-05-01 | Joint Stock Company «Biocad» | Cyclin-dependent kinase 7 inhibitors |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9012592D0 (en) | 1990-06-06 | 1990-07-25 | Smithkline Beecham Intercredit | Compounds |
| ES2301194T3 (es) * | 1997-02-05 | 2008-06-16 | Warner-Lambert Company Llc | Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular. |
| CN1158269C (zh) | 1997-10-27 | 2004-07-21 | 阿古龙制药公司 | 作为cdk抑制剂的取代的4-氨基-噻唑-2-基化合物 |
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| ATE245641T1 (de) | 1998-02-17 | 2003-08-15 | Tularik Inc | Antivirale pyrimidinderivate |
| AU5438299A (en) | 1998-08-29 | 2000-03-21 | Astrazeneca Ab | Pyrimidine compounds |
| GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| JP2003509425A (ja) | 1999-09-15 | 2003-03-11 | ワーナー−ランバート・カンパニー | キナーゼ阻害剤としてのプテリジノン |
| CA2386955A1 (en) | 1999-11-22 | 2001-05-31 | Warner-Lambert Company | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| WO2001055147A1 (en) * | 2000-01-25 | 2001-08-02 | Warner-Lambert Company | PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS |
| SK10772002A3 (sk) * | 2000-01-27 | 2004-01-08 | Warner-Lambert Company | Pyridopyrimidinónové deriváty na liečbu neurodegeneratívnych ochorení |
| GB0004888D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004886D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| BR0110302A (pt) | 2000-04-18 | 2003-01-14 | Agouron Pharma | Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase |
| AU2001290912A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| BR0116493A (pt) * | 2000-12-21 | 2003-09-30 | Vertex Pharma | Compostos de pirazol úteis como inibidores de proteìna cinase |
| IL159120A0 (en) | 2001-05-29 | 2004-05-12 | Schering Ag | Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| US7288547B2 (en) | 2002-03-11 | 2007-10-30 | Schering Ag | CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
| WO2004048343A1 (en) | 2002-11-28 | 2004-06-10 | Schering Aktiengesellschaft | Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| NZ541681A (en) * | 2003-02-10 | 2009-02-28 | Bayer Healthcare Ag | Treatment of bacterial diseases of the respiratory organs by locally applying ciprofloxacin and its salts |
| EP1605942A1 (en) | 2003-02-10 | 2005-12-21 | Pfizer Inc. | Regimen of administration for nelfinavir |
| DE10349423A1 (de) | 2003-10-16 | 2005-06-16 | Schering Ag | Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
-
2004
- 2004-02-02 US US10/770,379 patent/US7157455B2/en not_active Expired - Fee Related
- 2004-02-03 HR HR20050689A patent/HRP20050689A2/xx not_active Application Discontinuation
- 2004-02-03 BR BR0407381-9A patent/BRPI0407381A/pt not_active IP Right Cessation
- 2004-02-03 AU AU2004210408A patent/AU2004210408A1/en not_active Abandoned
- 2004-02-03 MX MXPA05008333A patent/MXPA05008333A/es active IP Right Grant
- 2004-02-03 EP EP04707513A patent/EP1628619A2/en not_active Withdrawn
- 2004-02-03 PL PL382309A patent/PL382309A1/pl not_active Application Discontinuation
- 2004-02-03 KR KR1020057014717A patent/KR100717099B1/ko not_active Expired - Fee Related
- 2004-02-03 EA EA200501233A patent/EA009412B1/ru not_active IP Right Cessation
- 2004-02-03 CA CA002512915A patent/CA2512915A1/en not_active Abandoned
- 2004-02-03 JP JP2006500021A patent/JP2006523183A/ja active Pending
- 2004-02-03 WO PCT/EP2004/000971 patent/WO2004069139A2/en not_active Ceased
- 2004-02-03 RS YUP-2005/0610A patent/RS20050610A/sr unknown
- 2004-02-06 AR ARP040100381A patent/AR043693A1/es not_active Application Discontinuation
- 2004-02-06 TW TW093102771A patent/TWI293881B/zh active
- 2004-02-06 MY MYPI20040366A patent/MY137555A/en unknown
- 2004-02-09 CL CL200400226A patent/CL2004000226A1/es unknown
-
2005
- 2005-07-11 IL IL169626A patent/IL169626A0/en unknown
- 2005-07-13 NO NO20053410A patent/NO20053410L/no not_active Application Discontinuation
- 2005-08-02 TN TNP2005000188A patent/TNSN05188A1/en unknown
- 2005-08-09 EC EC2005005958A patent/ECSP055958A/es unknown
- 2005-08-30 MA MA28472A patent/MA27716A1/fr unknown
-
2006
- 2006-06-20 US US11/471,001 patent/US7615634B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7157455B2 (en) | 2007-01-02 |
| MXPA05008333A (es) | 2005-09-30 |
| JP2006523183A (ja) | 2006-10-12 |
| US7615634B2 (en) | 2009-11-10 |
| US20040162303A1 (en) | 2004-08-19 |
| KR20050099544A (ko) | 2005-10-13 |
| KR100717099B1 (ko) | 2007-05-10 |
| US20060229330A1 (en) | 2006-10-12 |
| AR043693A1 (es) | 2005-08-10 |
| CL2004000226A1 (es) | 2005-01-14 |
| HRP20050689A2 (hr) | 2006-08-31 |
| WO2004069139A3 (en) | 2007-04-26 |
| ECSP055958A (es) | 2006-01-16 |
| MY137555A (en) | 2009-02-27 |
| WO2004069139A2 (en) | 2004-08-19 |
| CA2512915A1 (en) | 2004-08-19 |
| RS20050610A (sr) | 2007-12-31 |
| AU2004210408A1 (en) | 2004-08-19 |
| IL169626A0 (en) | 2007-07-04 |
| TWI293881B (en) | 2008-03-01 |
| EP1628619A2 (en) | 2006-03-01 |
| TNSN05188A1 (en) | 2007-06-11 |
| NO20053410L (no) | 2005-09-08 |
| PL382309A1 (pl) | 2007-08-20 |
| EA009412B1 (ru) | 2007-12-28 |
| TW200423940A (en) | 2004-11-16 |
| EA200501233A1 (ru) | 2006-04-28 |
| MA27716A1 (fr) | 2006-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0315912A (pt) | Compostos pirimìdicos com atividade antiproliferativa (ii) | |
| BRPI0606107A2 (pt) | compostos farmacêuticos, seus proocessos de preparação, usos dos mesmos na fabricação de medicamento e composição farmacêutica compreendendo os referidos compostos | |
| NO20090631L (no) | Morpholin pyrimidin derivativer anvendelige i behandlingen av proliferative lidelser | |
| BRPI0412820A (pt) | compostos de aminopirazol e utilização como inibidores de chk1 | |
| AU6422399A (en) | 6-substituted pyrazolo(3,4-d)pyrimidin-4-ones useful as cyclin dependent kinase inhibitors | |
| EA200900388A1 (ru) | Бензоксазолы и оксазолопиридины, применимые в качестве ингибиторов киназ janus | |
| NO20084496L (no) | Pyridyl- og pyrimidinylsubstituerte pyrrol-, tiofen- og furanderivater som kinaseinhibitorer | |
| BRPI0919873B8 (pt) | compostos de pirazol[1,5-a]pirimidina substituídos como inibidores da trk quinase, seus processos de preparação e composições farmacêuticas | |
| BRPI0312464B8 (pt) | compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos | |
| NO20082643L (no) | Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft | |
| BRPI0517634A (pt) | derivado de tiazol ou um derivado farmaceuticamente aceitável do mesmo, processo para a preparação de um composto, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição | |
| BR0211559A (pt) | Compostos, composições de ligantes tetracìclicos terapeuticamente úteis e seus usos | |
| BR9812048A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos de tratar uma doença mediada por uma cinase, de tratar a rejeição no transplante de órgão, e de tratar a alopecia induzida pela quimioterapia | |
| BRPI0910439B8 (pt) | derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos | |
| BR112013010564A8 (pt) | compostos heterocíclicos e usos dos mesmos | |
| BRPI0408990A (pt) | derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase | |
| NI201000143A (es) | Derivados bicíclicos heterocíclicos o espirobicíclicos heterocíclicos enlazados, de pirazolo[1,5-a] pirimidinas, procedimientos para su preparación y usos de los mismos. | |
| BRPI0606793A8 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação e uso do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de câncer e para a produção de um efeito anti-proliferativo em um animal de sangue quente, e, composição farmacêutica | |
| DE60215682D1 (de) | AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ | |
| BR0212896A (pt) | Derivados de 2-piridinil-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4- ona e 7-piridinil-2,3dihidroimidazo[1,2-a] pirimidin-5(1h)ona substituìdos | |
| BR0212435A (pt) | Derivados de 3-(4,5,6,7-tetraidroindol-2-ilmetilideno)-2-indolinona como inibidores de cinase | |
| BRPI0512253A (pt) | composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto | |
| BR0211203A (pt) | Acilsemicarbazidas como inibidores de cinase dependente de ciclina úteis como agentes anti-câncer e anti-proliferativos | |
| BR0213417A (pt) | Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos | |
| CO5611124A2 (es) | Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES. |